Jan 20, 2021 / 01:00PM GMT
Operator
Good day and welcome to the bintrafusp alfa update capital markets Q&A call. Today's conference is being recorded. At this time I would like to turn the conference over to Constantin Fest. Please go ahead sir.
Constantin Fest - Merck KGaA - Head of IR
Dear ladies and gentlemen, a very warm welcome to this Merck Capital Markets call. My name is Constantin Fest; I am Head of Investor Relations. And today we have this call to discuss today's news.
I'm delighted to have with me here today on this call Marcus Kuhnert, our Group CFO, as well as Peter Guenter, our CEO of the Healthcare Sector, as well as Danny Bar-Zohar, our Global Head of Development, and Rehan Verjee, President of EMD Serono and Global Head of Innovative Medicine Franchises, as well as Peter Halle, Head of Research, Global R&D Healthcare, to discuss all of your questions.
Without any further pause or delay, I would like directly to hand over to Marcus for a short introduction.
Marcus Kuhnert - Merck KGaA - CFO & Member of Executive Board<
Merck KGaA Bintrafusp alfa 037 Ad-Hoc - Capital Markets Q&A Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot